Skip to main content
. 2021 Oct 19;63(10):1323–1331. doi: 10.1177/02841851211041832

Fig. 3.

Fig. 3.

Forest plot displaying hazard ratios for death in main analysis parameters in patients with HCC treated with TACE. Objective response and disease control were calculated according to the mRECIST criteria for tumor response. CRP, C-reactive protein; HCC, hepatocellular carcinoma; mRECIST, modified Response and Evaluation Criteria in Solid Tumors; PPLE, peritumoral portal lipiodol enhancement; TACE, transarterial chemoembolization.